Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19548,137,1.57 [0.94-2.60],0.0829568882515403
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20392,154,1.15 [0.69-1.90],0.5959549160892587
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20178,1169,1.52 [1.28-1.81],2.5564232103675525e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,20402,309,1.68 [1.21-2.34],0.0020454992649405
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19796,2893,1.44 [1.29-1.62],2.2247743521275206e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19792,2930,1.37 [1.23-1.54],3.234333231543158e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,20221,877,1.27 [1.03-1.57],0.0268180678945784
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,20345,68,1.49 [0.71-3.11],0.2879228017298133
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18512,909,1.76 [1.45-2.14],9.946445662326803e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17846,997,1.72 [1.42-2.08],3.11312146361808e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17667,205,2.05 [1.39-3.01],0.0002855999441219
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14358,1904,1.33 [1.15-1.53],0.0001575832335202
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17607,336,1.69 [1.22-2.34],0.0015109074728612
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20393,1049,1.33 [1.10-1.61],0.0034492813157729
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,20479,386,1.61 [1.20-2.18],0.001728714467389
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19742,733,1.53 [1.23-1.91],0.0001266503888366
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20413,1002,1.76 [1.47-2.11],9.938281820557943e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19500,156,1.13 [0.68-1.87],0.6468676478688002
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20513,42,2.49 [1.13-5.48],0.0230415233112728
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,20285,874,1.73 [1.42-2.10],3.305112781339237e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20331,54,1.02 [0.43-2.43],0.9618799033958776
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20452,101,2.57 [1.52-4.36],0.0004392585092364
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20437,86,2.73 [1.56-4.77],0.0004252311074219
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19411,402,1.79 [1.34-2.39],7.018089808153166e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,19248,239,1.59 [1.08-2.33],0.0175718539893372
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19414,70,3.00 [1.61-5.60],0.0005636461595263
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20494,59,2.46 [1.25-4.83],0.0091963400405186
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20463,127,1.33 [0.77-2.30],0.2986516741825255
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral warts,20383,47,1.95 [0.87-4.36],0.1050441570974128
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20382,46,0.87 [0.33-2.24],0.7665961301141072
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,20246,302,0.88 [0.61-1.28],0.5087872878017782
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20454,43,0.79 [0.29-2.13],0.6441764629412443
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20418,50,0.78 [0.31-1.95],0.5970603126360617
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20474,108,0.83 [0.44-1.55],0.5617814766952836
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",20191,1410,1.02 [0.86-1.20],0.8497151455724656
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of meninges,20512,27,0.45 [0.13-1.60],0.2172468741640548
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20460,60,1.13 [0.50-2.55],0.7660692881994978
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20499,66,1.02 [0.47-2.23],0.9614685825373082
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20490,390,1.07 [0.77-1.47],0.692165971652212
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Caecum,20493,293,1.14 [0.79-1.64],0.4824664559853879
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20401,66,1.19 [0.55-2.56],0.6573872984964149
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Descending colon,20486,246,0.78 [0.52-1.18],0.2336693225278506
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,20448,362,0.81 [0.58-1.14],0.223168376617676
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20408,633,1.11 [0.87-1.43],0.3995543153791719
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20476,477,1.13 [0.85-1.50],0.4143891939937826
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15980,64,4.16 [2.65-6.52],5.144209748852256e-10
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15978,62,1.98 [0.99-3.98],0.0538215995914841
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20484,80,0.84 [0.41-1.73],0.632131489760476
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",20484,77,0.87 [0.41-1.81],0.7034035170498019
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lung cancer and mesothelioma,13671,307,1.20 [0.85-1.71],0.2977279922925997
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,15974,58,4.08 [2.54-6.55],5.5724375672154615e-09
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16084,168,1.40 [0.88-2.22],0.1582505385935381
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16161,245,1.57 [1.09-2.28],0.0164800985924523
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15997,81,3.41 [2.15-5.41],1.823850821046917e-07
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16031,115,0.81 [0.44-1.48],0.4899679694397177
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16044,128,1.59 [0.94-2.70],0.0820111400634664
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15983,67,0.62 [0.37-1.04],0.0719305483670638
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17098,1182,0.95 [0.79-1.14],0.5712742130859214
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16045,129,1.50 [0.89-2.55],0.1287692652032977
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16010,94,1.04 [0.54-2.00],0.9071316274223692
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16023,107,1.40 [0.78-2.49],0.2568958065726374
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,20410,149,0.80 [0.47-1.36],0.4013323060956689
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of trunk,20486,86,0.91 [0.45-1.82],0.7808736189014371
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanoma in situ,15944,63,1.01 [0.46-2.26],0.9716187753550364
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16005,89,2.50 [1.48-4.22],0.0005726788345393
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16058,142,2.13 [1.36-3.33],0.0009614225164238
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16113,197,1.00 [0.64-1.56],0.9983774337062844
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16004,88,2.09 [1.18-3.70],0.0115451382095952
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,20400,124,1.16 [0.66-2.03],0.6074166565078991
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16939,1023,1.04 [0.85-1.27],0.711066955115055
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17001,1085,1.10 [0.90-1.33],0.352791730797127
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,20282,258,1.67 [1.16-2.41],0.0055215848137438
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,19061,67,1.42 [0.69-2.93],0.3455229223755275
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,20081,57,1.51 [0.67-3.37],0.3169925707702015
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20067,2321,1.35 [1.19-1.53],4.849116560031352e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19468,53,1.11 [0.46-2.65],0.8172766194489693
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,20154,42,2.86 [1.40-5.82],0.0038631217101362
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20218,1224,1.27 [1.06-1.51],0.0085556019279027
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20216,1222,1.26 [1.06-1.51],0.0092448818722017
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,19075,81,2.38 [1.36-4.17],0.0023753693367093
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,20323,908,1.46 [1.19-1.78],0.0002211545043337
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,20208,96,1.08 [0.56-2.06],0.8191297365583807
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,20086,62,2.07 [1.03-4.15],0.0415131557602967
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,20080,56,2.06 [1.01-4.18],0.0467196192587
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20368,256,1.92 [1.35-2.72],0.0002461332043362
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20431,40,2.13 [0.88-5.16],0.0942205944578361
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",20320,208,1.86 [1.26-2.75],0.0018167746122
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19477,62,0.89 [0.39-2.00],0.7740607805188905
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15181,308,1.66 [1.19-2.32],0.0029238846423693
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18744,136,1.10 [0.64-1.86],0.7350137597257249
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18772,164,1.41 [0.90-2.21],0.1294245665332631
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14925,52,1.94 [0.89-4.24],0.097690643665232
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,19361,54,1.12 [0.47-2.64],0.7999192794434999
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18707,186,0.98 [0.61-1.56],0.921537644337896
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",20121,491,1.07 [0.81-1.42],0.6361356803596816
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19829,199,0.79 [0.50-1.25],0.3131661620760419
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19748,118,0.69 [0.38-1.27],0.2309719319001913
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,20256,949,1.32 [1.08-1.61],0.0068600605350635
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17589,916,1.39 [1.14-1.70],0.0013940370049737
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14936,63,1.21 [0.55-2.67],0.6342985770192694
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19798,35,1.08 [0.37-3.15],0.8853181343031872
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15099,226,1.34 [0.89-2.02],0.1595003207992842
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14935,62,1.07 [0.48-2.39],0.8784111816555081
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18171,3298,1.18 [1.06-1.32],0.0025012979944881
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15031,158,1.25 [0.76-2.06],0.3748515505532475
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15349,476,1.21 [0.91-1.61],0.1906906652203853
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20466,228,1.66 [1.13-2.46],0.0105245209130487
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,20309,71,0.54 [0.25-1.18],0.1240219595375804
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15005,132,1.63 [0.97-2.75],0.0661797492507819
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14927,54,2.95 [1.59-5.47],0.0005737258033823
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20360,597,1.70 [1.34-2.16],1.1700344370663014e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15126,253,1.81 [1.26-2.60],0.0012016186768248
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15166,293,1.43 [1.01-2.04],0.0446472112278635
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15493,620,1.10 [0.86-1.42],0.4425910664959389
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14988,115,1.60 [0.92-2.78],0.0969749354824403
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,20303,65,0.52 [0.23-1.17],0.115463753663975
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15366,493,1.55 [1.19-2.01],0.0010165974841954
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15217,344,1.83 [1.34-2.50],0.0001368449621364
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18570,49,1.51 [0.64-3.55],0.3459163054484087
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19320,4447,1.23 [1.12-1.35],1.5071176770751296e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19774,11,1.87 [0.35-10.09],0.4642853986482371
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19784,21,1.20 [0.31-4.62],0.7911547518553023
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20372,1513,1.16 [0.99-1.36],0.0732637813295343
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20369,1509,1.15 [0.98-1.35],0.0910362670724126
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19775,12,2.81 [0.73-10.81],0.1335921029258343
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,20283,688,1.15 [0.91-1.46],0.2433223852443767
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16239,1366,1.54 [1.31-1.81],9.395048362709378e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20504,202,1.87 [1.26-2.78],0.0020606238830438
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19716,86,1.14 [0.58-2.24],0.7013769687558826
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19660,65,1.04 [0.48-2.30],0.9136434946889704
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19669,74,1.15 [0.55-2.39],0.7169657496447385
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14932,59,1.04 [0.45-2.37],0.933458286798342
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,18124,145,2.47 [1.58-3.85],6.810478948786194e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2160,104,2.03 [1.15-3.55],0.0138977120232162
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2300,272,0.83 [0.57-1.20],0.3180994548319434
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,18060,81,3.03 [1.72-5.32],0.0001158348059247
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2116,60,2.13 [1.04-4.39],0.0391293602733038
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19860,1881,1.75 [1.53-2.00],6.84535416826635e-16
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19904,274,1.10 [0.75-1.60],0.6224107953678603
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18723,202,1.29 [0.84-1.99],0.2521815134115858
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15521,648,1.67 [1.33-2.10],1.2635413907447996e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20404,210,1.44 [0.95-2.19],0.0884094434318665
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19486,234,1.46 [1.00-2.14],0.0528568695371697
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,18045,1266,1.20 [1.01-1.43],0.0412223609136045
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19584,332,1.41 [1.01-1.95],0.0409337377223252
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,19321,69,2.05 [1.09-3.87],0.0255943783532811
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19447,195,2.38 [1.66-3.41],2.121324877694117e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12011,1948,1.28 [1.10-1.48],0.0009620208145468
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,AV-block,16555,512,1.04 [0.79-1.39],0.7656583322628064
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20453,440,0.82 [0.60-1.12],0.2138327499045319
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,10277,214,2.48 [1.76-3.49],2.2442665841872338e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16219,176,1.25 [0.78-2.01],0.3594537417461719
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16136,93,1.45 [0.76-2.76],0.2576902707065426
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20513,50,2.14 [1.02-4.49],0.0450072230990212
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,17189,1146,1.18 [0.98-1.43],0.0753138638969541
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19007,2249,1.32 [1.16-1.51],2.071986902760724e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17363,6723,1.19 [1.10-1.29],1.239986346910928e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19459,231,1.67 [1.13-2.46],0.0096486354864567
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Endocarditis,16115,72,1.22 [0.58-2.55],0.5996855945980493
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",20244,1126,1.44 [1.21-1.72],5.637951797278858e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,18382,5842,1.17 [1.07-1.27],0.0002945125162865
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18386,5846,1.16 [1.06-1.26],0.000565178954541
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20311,98,4.82 [3.39-6.85],1.6291654666828751e-18
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12714,174,2.74 [1.96-3.83],3.6275756759487996e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12644,104,1.79 [1.04-3.07],0.036226891647848
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,20388,1018,1.24 [1.02-1.50],0.0314876352170213
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19614,96,1.06 [0.56-2.02],0.8580763293538678
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19130,2351,1.29 [1.14-1.47],6.720217201102699e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",20160,555,1.47 [1.14-1.89],0.0029817963941011
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16390,347,1.49 [1.07-2.07],0.0169534335220025
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19914,911,1.34 [1.10-1.64],0.0045070654631239
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17570,791,1.44 [1.16-1.79],0.0008638217580083
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20376,195,1.43 [0.93-2.20],0.0999424535716273
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20469,321,1.40 [1.00-1.96],0.0518983211884842
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Oesophageal varices,19284,56,5.76 [3.83-8.68],4.6676818192231084e-17
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other aneurysm,19330,78,0.84 [0.41-1.75],0.6496057531750188
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,16452,409,1.48 [1.09-2.01],0.0116049132365601
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,19364,112,1.80 [1.07-3.04],0.0281030877445725
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19485,233,1.97 [1.38-2.82],0.000188822749712
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16202,159,1.51 [0.93-2.45],0.09906332956119
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other disorders of veins,19304,76,1.66 [0.84-3.27],0.145543838722725
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,19270,42,1.40 [0.55-3.58],0.4832855660334051
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,19191,78,1.12 [0.55-2.30],0.7578719476481927
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,19316,88,1.57 [0.83-2.96],0.1660965150719927
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17097,1054,1.30 [1.08-1.58],0.0065942992527028
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19425,55,4.64 [2.93-7.34],5.309217352906793e-11
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19724,472,1.41 [1.07-1.86],0.014552043967172
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19957,320,2.19 [1.63-2.95],1.9522414051948298e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19664,551,1.09 [0.84-1.43],0.5166599091678339
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10376,313,1.39 [0.97-1.98],0.0693125300990165
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19644,435,1.71 [1.29-2.25],0.0001558724193262
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19525,297,1.42 [1.00-2.03],0.0526755532157497
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,20059,422,0.98 [0.72-1.34],0.9122369608913964
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20458,601,1.65 [1.30-2.10],4.336285327128611e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16446,403,1.16 [0.85-1.59],0.3488151160638936
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19956,319,2.19 [1.63-2.94],2.268029451359015e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,19299,186,1.60 [1.03-2.49],0.0359608271665746
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",20147,629,1.39 [1.09-1.77],0.0071209336043827
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",20136,653,1.36 [1.08-1.73],0.0103796036165983
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19599,38,0.90 [0.32-2.55],0.8403573925400873
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,19349,98,1.48 [0.81-2.72],0.2030552554685716
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19807,202,0.89 [0.56-1.39],0.5990646156304592
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,19266,263,1.48 [1.02-2.14],0.0394626586169278
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,19553,325,1.22 [0.86-1.73],0.2578424802972106
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,19268,62,1.21 [0.55-2.67],0.6299540409403112
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,20301,658,1.09 [0.85-1.39],0.5050699348539462
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20335,426,1.11 [0.82-1.50],0.5136601164131738
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17678,831,1.17 [0.94-1.45],0.1644658802096818
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,19915,3068,1.09 [0.97-1.22],0.1316999146634903
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20281,495,1.08 [0.81-1.43],0.5970996381839508
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17829,982,1.34 [1.10-1.63],0.0037574758709864
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16910,63,0.81 [0.36-1.81],0.6032166374996517
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,19942,1322,1.21 [1.03-1.42],0.0239730743942404
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18446,1599,1.15 [0.99-1.33],0.0675924646076299
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Vascular dementia,20124,124,1.16 [0.66-2.03],0.6006231698005755
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Alzheimer disease,20513,249,0.83 [0.55-1.26],0.3864336906309508
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13745,50,0.46 [0.18-1.19],0.1077444449794588
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Bell's palsy,19341,68,1.98 [0.98-3.98],0.0563258713660457
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19566,293,0.70 [0.48-1.03],0.0690887108633598
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral cysts,20173,199,1.37 [0.89-2.11],0.1583797462184358
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20438,291,1.15 [0.80-1.66],0.4406469302642924
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,20100,55,1.13 [0.49-2.63],0.7695192319605446
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20497,68,1.19 [0.56-2.53],0.6553821127668547
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",20051,77,1.22 [0.60-2.47],0.5899422859538288
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,19142,235,1.33 [0.89-1.99],0.1621882193185638
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,20060,1153,1.29 [1.07-1.55],0.006916063129414
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20481,405,0.86 [0.63-1.19],0.3732216898945385
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,20041,1821,1.12 [0.97-1.30],0.1199129927350428
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Generalized epilepsy,20190,51,1.80 [0.80-4.01],0.1534265480643397
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,20374,227,1.21 [0.80-1.83],0.3572556468873171
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hydrocephalus,20021,47,0.70 [0.27-1.83],0.4694143261998428
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20497,53,2.06 [0.95-4.45],0.067398716613032
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,19293,20,1.37 [0.35-5.43],0.6507550443596866
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,19353,80,0.91 [0.45-1.86],0.7991372712538136
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Memory loss,19986,105,0.98 [0.52-1.83],0.9468547247949768
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,19071,164,1.21 [0.74-1.97],0.4570181099829157
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20493,149,1.38 [0.84-2.29],0.2074158362590835
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Motor neuron disease,13848,141,0.90 [0.52-1.56],0.7159956218262101
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20411,59,1.36 [0.62-3.02],0.4423321876461176
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",20099,826,1.06 [0.85-1.32],0.6237740026275538
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,19378,3020,1.10 [0.98-1.23],0.1148005204333297
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,20233,188,1.16 [0.74-1.82],0.5273547674962151
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19588,315,1.27 [0.90-1.81],0.175019828733182
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20434,298,1.82 [1.30-2.54],0.0004584061764844
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16205,518,1.11 [0.84-1.48],0.4583189565942651
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,20038,64,0.94 [0.42-2.09],0.87505783976813
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,20103,129,1.04 [0.59-1.81],0.9024834236459548
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,20188,112,0.73 [0.39-1.35],0.3097875312243184
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,19358,85,1.82 [0.96-3.44],0.0647917341375863
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other headache syndromes,18941,34,1.32 [0.45-3.84],0.6104565223628748
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,20414,440,1.02 [0.75-1.38],0.8971269585566783
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,19504,597,1.38 [1.07-1.77],0.0118240438517978
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Parkinson's disease,20492,274,0.94 [0.64-1.39],0.7684716719368724
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19997,23,1.33 [0.37-4.83],0.6607378468860061
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Restless leg syndrome,20512,36,1.24 [0.45-3.48],0.6771327989715268
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,20261,539,1.44 [1.11-1.87],0.0062654542218626
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,20185,49,2.76 [1.32-5.74],0.0067473116006391
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20496,162,0.87 [0.52-1.44],0.5791822923062009
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,19302,29,1.16 [0.36-3.71],0.8016581941125271
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20513,252,0.85 [0.56-1.27],0.4230681797281613
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),20097,120,1.18 [0.67-2.08],0.5573692547360777
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,20059,73,1.33 [0.65-2.71],0.4336378236952177
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,20221,251,0.87 [0.58-1.32],0.5186521737023564
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,20358,253,1.38 [0.94-2.02],0.0976156018401776
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19756,39,0.35 [0.12-1.02],0.0538682007109947
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19772,55,1.37 [0.60-3.13],0.4534566053317919
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20435,34,0.67 [0.22-2.05],0.4833761910138093
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,20324,104,1.25 [0.69-2.28],0.4670201291751426
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2116,60,2.14 [1.04-4.41],0.0380200389334212
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2582,109,2.19 [1.27-3.75],0.0044785172012336
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,20068,82,1.05 [0.52-2.12],0.8958331825533201
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,20325,856,1.11 [0.90-1.38],0.3321955025682881
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",20246,529,0.90 [0.68-1.19],0.4563941749325353
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19834,117,1.08 [0.60-1.92],0.8068541978832461
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20451,481,0.88 [0.66-1.19],0.4066271962607913
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20511,56,0.54 [0.22-1.31],0.1748966347747762
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20396,426,0.78 [0.57-1.07],0.1177426892898937
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20481,261,1.25 [0.86-1.84],0.2455524530862393
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20438,131,1.00 [0.57-1.75],0.9981906503631292
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19783,66,1.81 [0.92-3.55],0.0860182902814254
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19791,74,0.76 [0.35-1.62],0.4732592889552497
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19751,34,1.27 [0.44-3.63],0.6584563789267359
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20433,583,0.99 [0.76-1.29],0.9379770869675438
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,20018,168,0.52 [0.31-0.86],0.0118011454699435
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19994,24,0.97 [0.26-3.55],0.9627386546491912
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,20300,80,1.52 [0.78-2.96],0.2191532055641616
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20405,185,1.20 [0.76-1.89],0.440246789688926
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,20117,147,0.61 [0.35-1.05],0.0721605874167507
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,20376,69,0.81 [0.37-1.78],0.5974548158253383
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,20229,379,1.18 [0.86-1.63],0.313583032223112
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,20086,100,1.32 [0.71-2.44],0.3763273579234849
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,19361,1516,1.09 [0.93-1.29],0.2735962963597173
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20382,162,1.37 [0.85-2.20],0.1994957668328614
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20497,122,1.24 [0.71-2.17],0.4557147101327177
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,20082,365,0.93 [0.66-1.30],0.6684383151775083
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,20277,57,1.51 [0.69-3.30],0.2994628217508361
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20501,46,0.41 [0.15-1.08],0.0696035679899377
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19779,62,0.85 [0.37-1.95],0.7087203311433578
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19846,129,0.74 [0.42-1.31],0.3025293231340484
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19575,106,1.36 [0.76-2.45],0.3020817955229534
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,20010,40,1.46 [0.57-3.77],0.4301720758219263
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19526,57,0.69 [0.29-1.66],0.4076427096616817
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19894,44,0.38 [0.14-1.05],0.062887074546883
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",20022,172,0.94 [0.58-1.53],0.8047763082507102
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19813,96,0.90 [0.47-1.73],0.7475176752440631
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19575,106,1.27 [0.69-2.33],0.4356584490060151
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19547,78,1.10 [0.54-2.24],0.7827601818621636
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19076,1231,0.99 [0.83-1.19],0.9479409037792628
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19765,48,0.59 [0.23-1.53],0.2793062205619485
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,20307,321,1.20 [0.85-1.70],0.2962273911527758
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,20044,58,1.23 [0.55-2.75],0.617727720878548
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),20115,129,1.80 [1.08-2.98],0.0239981663194862
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,20353,50,1.22 [0.50-2.96],0.661172716404371
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20477,107,0.88 [0.47-1.64],0.6844868753389344
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20397,99,1.85 [1.04-3.30],0.035600128309338
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,20349,46,0.47 [0.18-1.23],0.1229253116278445
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,20350,47,0.66 [0.26-1.73],0.401143629238015
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20427,801,1.15 [0.92-1.44],0.2138102049996761
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,20219,593,1.22 [0.94-1.57],0.132668523801062
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19740,114,0.65 [0.35-1.21],0.1735388044213435
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19696,70,1.26 [0.60-2.64],0.5408969567389794
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute pharyngitis,20327,47,1.15 [0.47-2.87],0.7568294834892579
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20439,159,1.31 [0.80-2.14],0.2811937599651684
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20334,54,1.35 [0.59-3.11],0.4808731072944594
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza,18588,86,1.36 [0.70-2.64],0.3594958139592453
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18585,83,1.44 [0.74-2.80],0.2816738068713461
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13456,92,2.10 [1.14-3.86],0.0169884680577307
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic rhinitis,20424,240,1.17 [0.78-1.76],0.4434472989908621
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14307,1240,1.29 [1.08-1.54],0.0054931872168027
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14579,1215,1.26 [1.05-1.52],0.0111909397206439
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),20176,124,2.18 [1.35-3.52],0.0014570415897706
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18578,76,1.68 [0.86-3.28],0.1264079316170312
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,17811,252,1.51 [1.04-2.20],0.0315794392494066
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17596,37,1.78 [0.68-4.66],0.2409381859929719
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19774,2215,1.30 [1.14-1.48],0.0001151223252244
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19254,69,1.46 [0.71-3.02],0.3054908789321233
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,19318,133,1.03 [0.59-1.78],0.9229143751020044
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",20325,1129,1.47 [1.22-1.76],3.064753796312119e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,19312,127,1.24 [0.72-2.16],0.4387471426544602
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18768,4513,1.26 [1.14-1.38],1.8793226980860176e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19531,346,1.38 [0.99-1.91],0.0555247757876659
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,19476,280,1.85 [1.31-2.61],0.0004909498601593
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,17873,314,1.51 [1.07-2.11],0.0179546018980573
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19695,307,1.66 [1.19-2.30],0.0027927015681864
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20297,1795,1.45 [1.26-1.67],3.277589562095163e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,19717,329,1.68 [1.23-2.31],0.0012615319947052
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Later onset COPD,19562,849,1.35 [1.09-1.66],0.0053874278763513
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20496,338,1.39 [1.00-1.93],0.0513073491495511
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,19315,130,0.82 [0.47-1.45],0.4954623445345301
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,20276,834,1.62 [1.32-1.99],3.5645567162902204e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,20268,1884,1.50 [1.31-1.72],9.099155057841252e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19951,766,1.12 [0.89-1.40],0.3377920305844283
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,18437,53,2.90 [1.44-5.86],0.0029118823798624
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20417,402,1.84 [1.39-2.43],2.029603077507847e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20403,1196,1.49 [1.25-1.78],6.1048643541752645e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,19332,948,1.78 [1.47-2.15],3.9197978864810884e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural plaque,18616,232,1.71 [1.16-2.52],0.0066209245491688
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20079,1577,1.46 [1.26-1.70],7.380727793296588e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20406,248,1.53 [1.05-2.24],0.0265978654311432
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumothorax,18504,120,1.26 [0.71-2.23],0.437827538257811
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pollen allergy,20499,208,1.19 [0.77-1.84],0.4394818426951924
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,20074,59,3.63 [2.12-6.21],2.6370585945306167e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13415,51,0.84 [0.34-2.07],0.7082281168998539
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,20259,817,1.66 [1.35-2.04],1.191111938514258e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19426,241,1.18 [0.79-1.77],0.4290926085487877
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Viral pneumonia,18732,230,1.43 [0.96-2.14],0.0783006345441517
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",20195,196,1.43 [0.93-2.21],0.1027860909830763
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8993,100,1.19 [0.62-2.27],0.6027251854381813
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14373,75,1.00 [0.48-2.10],0.9950131275902604
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,20400,125,1.33 [0.77-2.31],0.3049058543972169
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute gastritis,15532,73,1.94 [0.99-3.82],0.0549147980880377
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,19354,177,1.20 [0.74-1.93],0.4581854635410877
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute peritonitis,20198,79,2.09 [1.13-3.84],0.0183227854678224
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19736,97,5.66 [3.93-8.15],1.2400302856003111e-20
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Barrett oesophagus,15905,446,0.97 [0.71-1.31],0.826751578832104
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",19281,104,2.19 [1.25-3.85],0.0061842949193194
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",20162,104,2.03 [1.19-3.45],0.0092550208495564
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,19364,187,1.38 [0.87-2.17],0.1728131365194952
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,19863,686,1.88 [1.50-2.35],3.375871656151494e-08
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,15680,221,1.55 [1.03-2.33],0.036270374553494
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,19224,47,2.45 [1.09-5.51],0.0296583985733782
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20334,121,4.99 [3.65-6.84],1.1022546683954905e-23
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,19102,77,2.06 [1.09-3.88],0.0263669178353093
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Collagenous colitis,19270,42,1.28 [0.49-3.30],0.6162910431716642
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20363,190,1.38 [0.89-2.15],0.1552092143930889
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,20371,1321,1.18 [0.99-1.40],0.0635486891373272
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,19307,79,1.51 [0.76-2.97],0.237765306505195
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",20216,58,1.35 [0.61-3.03],0.459610527885566
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,19294,66,1.85 [0.91-3.74],0.0888132920458026
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,19967,191,1.15 [0.73-1.81],0.546554568138957
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17391,1660,1.14 [0.98-1.33],0.0964702867664574
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,20426,151,1.21 [0.73-2.01],0.4642281318901445
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,20392,753,2.47 [2.04-2.99],3.617666366930401e-20
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18788,3329,1.12 [1.00-1.25],0.0433677337458279
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",20203,427,1.23 [0.91-1.67],0.1754616843998109
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20471,352,1.26 [0.91-1.76],0.1693665744638686
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19866,90,1.20 [0.62-2.32],0.5888104253688868
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19752,50,1.01 [0.41-2.50],0.9807922793221844
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,20241,1216,1.29 [1.08-1.54],0.0046650945983663
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of tongue,19763,98,1.59 [0.86-2.93],0.1384127382710255
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",20212,1035,1.75 [1.45-2.10],2.6731944774583515e-09
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16923,2625,0.97 [0.86-1.10],0.6447122617571697
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,15677,218,1.39 [0.92-2.12],0.1179635797170632
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20407,168,1.46 [0.92-2.32],0.1103003796789615
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20453,36,0.50 [0.17-1.51],0.2181362807557702
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19779,140,5.35 [3.89-7.35],5.062427973214646e-25
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14451,153,1.21 [0.72-2.00],0.4717218767242724
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,15812,353,0.90 [0.64-1.28],0.5690774488761445
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,15774,315,1.49 [1.06-2.09],0.0214731113531545
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,17305,1846,1.17 [1.01-1.36],0.035253356373923
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15960,501,1.39 [1.06-1.83],0.017017210930578
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15699,6856,1.14 [1.06-1.24],0.0006154270219816
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,20031,1006,1.28 [1.05-1.56],0.0132493224268455
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19821,45,1.25 [0.49-3.18],0.6386749714029047
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15106,1042,0.95 [0.78-1.16],0.6106068274632077
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19710,71,4.56 [2.83-7.34],4.2612649634676016e-10
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,18745,3014,1.06 [0.94-1.19],0.332080260955441
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,20456,35,0.52 [0.17-1.60],0.2560999641407773
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impaction of intestines,14336,38,0.88 [0.30-2.53],0.8071821541225273
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,17130,1399,0.96 [0.81-1.14],0.6299135173893922
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15897,166,0.58 [0.35-0.97],0.0372080339954868
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14375,77,0.67 [0.32-1.42],0.2953147876026923
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,19114,89,1.95 [1.07-3.57],0.0299680754751083
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14540,242,0.96 [0.63-1.45],0.8337532867393079
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20476,320,2.12 [1.55-2.90],2.682147247014892e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19807,579,1.37 [1.07-1.77],0.0141650879589791
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19990,762,1.34 [1.07-1.67],0.0098574954054101
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15640,181,1.72 [1.10-2.68],0.0163880536367874
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,15998,539,1.34 [1.02-1.75],0.0333245396946635
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20465,94,1.64 [0.89-3.01],0.1137023847055486
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15794,63,0.95 [0.42-2.16],0.90759392333816
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15546,1248,1.16 [0.97-1.39],0.0969953291636982
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,19397,220,1.62 [1.07-2.44],0.0222611178541447
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,19279,102,1.78 [0.97-3.24],0.06083687097423
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,15934,1636,1.15 [0.99-1.35],0.0728825174572955
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,18959,4661,1.06 [0.96-1.16],0.2332093665290096
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19734,155,1.91 [1.19-3.05],0.0070963811095301
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,20240,601,2.51 [2.03-3.11],3.3155570105519855e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16084,625,1.23 [0.96-1.58],0.1061033056785171
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,19295,118,1.44 [0.82-2.53],0.2029441435008518
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20416,297,1.08 [0.74-1.55],0.6964871064448089
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16133,674,1.66 [1.32-2.08],1.6299789231780855e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,20040,1015,1.29 [1.06-1.57],0.0095609856678421
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19922,146,1.50 [0.91-2.48],0.1111763327906124
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15651,1353,1.18 [1.00-1.41],0.0525778848863759
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17054,1595,1.17 [1.00-1.37],0.0500067412565756
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19721,82,3.32 [1.93-5.72],1.5217101531590424e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19894,666,1.34 [1.06-1.70],0.01555524040785
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14596,298,1.19 [0.83-1.71],0.3509389783325644
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20444,43,0.52 [0.19-1.44],0.210071133139762
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14704,406,1.13 [0.83-1.55],0.4377198443375023
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",19171,146,1.21 [0.72-2.04],0.462858594986565
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20501,36,1.19 [0.42-3.39],0.7476688631045066
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19782,86,1.06 [0.53-2.12],0.8632250266816895
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Toxic colitis,19268,40,1.73 [0.70-4.30],0.2369981048054414
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15722,263,1.13 [0.77-1.67],0.5341804676113207
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,19355,127,1.39 [0.80-2.40],0.237304302320481
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19333,105,1.38 [0.75-2.51],0.2990533163989242
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,16045,314,0.87 [0.60-1.25],0.45076721039962
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14434,136,1.30 [0.76-2.22],0.3367514982758278
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,15954,223,1.48 [0.97-2.24],0.066179279145324
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Volvulus,14360,62,0.85 [0.37-1.95],0.707734141598066
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20457,273,0.95 [0.65-1.41],0.8127793116357975
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,20246,61,3.61 [2.03-6.44],1.3316291797472831e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18835,80,1.63 [0.84-3.16],0.1477700084378836
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19881,649,1.67 [1.32-2.11],1.4432913881398943e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19408,176,1.11 [0.69-1.78],0.665172299071618
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,19133,378,1.43 [1.05-1.95],0.02449233410346
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,20260,229,1.23 [0.82-1.86],0.3160279666126372
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20429,398,1.03 [0.75-1.41],0.8570743107185009
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,20071,40,1.36 [0.51-3.60],0.5365538989820474
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19229,2696,1.18 [1.04-1.33],0.0077308676661348
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,20117,347,1.06 [0.75-1.49],0.7412166340772993
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,20017,247,1.03 [0.69-1.54],0.8949786374704344
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,20114,882,1.51 [1.23-1.85],6.902673394464155e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20503,25,1.08 [0.30-3.83],0.905321385934851
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18778,23,3.55 [1.34-9.35],0.0105588420054544
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19822,52,1.12 [0.47-2.67],0.8002445738182783
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,20256,225,1.24 [0.82-1.88],0.2981808458172655
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,19171,416,1.02 [0.75-1.40],0.8799315211418548
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18821,66,1.00 [0.46-2.18],0.992330190711614
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20455,70,1.97 [1.01-3.82],0.0460686876754328
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19402,170,1.49 [0.94-2.36],0.0936940439711033
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,20366,181,1.33 [0.84-2.10],0.2194016899541227
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,20088,57,0.87 [0.37-2.04],0.7423859725986597
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18809,54,0.42 [0.17-1.05],0.0629652292572792
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20120,1365,1.26 [1.06-1.49],0.0075873755062018
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",19207,452,1.12 [0.83-1.51],0.4410083870526649
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18824,69,1.03 [0.48-2.20],0.9448172706688912
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20436,251,1.28 [0.86-1.89],0.2210950802509116
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,20077,46,0.63 [0.24-1.66],0.3504695893688483
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20405,220,1.47 [0.98-2.21],0.0608056239671873
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20473,289,0.93 [0.64-1.36],0.7116264084696748
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18831,76,1.56 [0.79-3.09],0.203661542756327
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18981,226,0.94 [0.61-1.45],0.7827325970191594
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20467,283,0.98 [0.67-1.43],0.901189710699111
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18966,211,2.08 [1.42-3.06],0.0001758326075352
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20490,105,1.81 [1.04-3.17],0.0373727675176972
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17697,71,1.87 [0.93-3.76],0.0784142562094695
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18705,4082,1.13 [1.02-1.25],0.0162899295795574
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17502,2879,0.98 [0.87-1.11],0.76774046797847
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17690,64,1.34 [0.61-2.91],0.4647071246683425
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18048,122,1.15 [0.65-2.04],0.6298995811619967
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18046,120,1.26 [0.71-2.23],0.4276355969568149
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,20334,56,1.17 [0.51-2.70],0.7120549035221776
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17992,66,0.51 [0.22-1.15],0.1057912668008056
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15362,739,1.00 [0.79-1.27],0.9846057856911548
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20407,128,0.82 [0.46-1.45],0.4860537379108928
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18149,223,1.13 [0.74-1.73],0.5603841815192728
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17447,5336,1.08 [0.99-1.18],0.0830972945457552
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19620,85,2.47 [1.40-4.35],0.0017445596266557
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17768,142,1.07 [0.63-1.81],0.8079944395234764
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,18014,388,1.01 [0.73-1.40],0.9615379865979344
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19799,1873,1.17 [1.01-1.35],0.03611012080923
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17946,320,0.96 [0.67-1.38],0.8383757659604603
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17674,48,1.73 [0.74-4.06],0.205917420067501
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17712,86,0.42 [0.21-0.86],0.0173557678371055
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,20233,27,0.99 [0.29-3.36],0.9879140371900136
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15868,1245,0.86 [0.71-1.04],0.1144236782997234
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15444,821,1.30 [1.05-1.62],0.0185977688759373
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20393,808,1.25 [1.01-1.56],0.0419400604789622
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14659,36,0.33 [0.11-1.03],0.0554047096014378
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14692,69,0.76 [0.34-1.71],0.5122095683795498
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17850,224,1.40 [0.92-2.11],0.1119808898277365
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,15166,543,0.99 [0.74-1.30],0.9180105910909993
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17960,34,2.23 [0.91-5.45],0.0776931098906725
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18367,441,1.35 [1.01-1.81],0.0454595241775821
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18145,219,0.98 [0.63-1.51],0.9123342709858536
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,15130,507,0.92 [0.68-1.23],0.5584876185765859
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17682,56,1.33 [0.58-3.04],0.5001284411737681
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17668,42,2.78 [1.27-6.09],0.0105884685519329
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19614,79,2.54 [1.39-4.64],0.0023488670499111
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20266,731,1.40 [1.12-1.75],0.0035689200944983
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19872,337,1.22 [0.87-1.71],0.2506537217941482
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20446,255,1.63 [1.13-2.34],0.0092514593290658
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16229,1606,1.19 [1.02-1.40],0.0286214023546094
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14668,45,1.24 [0.48-3.23],0.6598431786033059
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17693,67,0.96 [0.44-2.10],0.9134405729420988
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14672,49,1.26 [0.51-3.12],0.6190054840391453
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14661,38,1.72 [0.64-4.64],0.2838576982384037
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19693,158,0.81 [0.48-1.36],0.4209705774013884
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19671,136,1.54 [0.92-2.57],0.0984233801898627
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20484,74,1.14 [0.55-2.36],0.7265738677480554
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19202,1276,1.24 [1.04-1.48],0.0143059861872172
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17683,57,1.09 [0.47-2.53],0.8441585455706055
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14657,34,0.67 [0.21-2.12],0.4921058716519697
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18446,520,1.38 [1.06-1.81],0.018304028461672
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16082,1459,1.09 [0.92-1.29],0.3028127756964736
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,20251,45,1.58 [0.66-3.81],0.3084326179826562
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20499,55,3.62 [1.96-6.67],3.751150001913038e-05
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17697,71,0.84 [0.39-1.82],0.6662693251085219
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18456,830,1.38 [1.12-1.71],0.0028675296974396
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17705,79,1.31 [0.65-2.62],0.4496364229039105
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15663,1040,1.21 [0.99-1.47],0.0592923811903179
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19607,72,0.74 [0.34-1.60],0.4461452965499944
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17664,38,1.10 [0.39-3.15],0.8547096103397867
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18023,97,1.12 [0.59-2.14],0.7252399259373576
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18048,422,1.39 [1.03-1.87],0.032288153920603
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,20372,166,0.91 [0.55-1.51],0.7267086979571222
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18333,407,1.32 [0.97-1.79],0.0791601646275224
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20454,252,1.73 [1.20-2.48],0.0031847604231159
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20501,34,2.93 [1.31-6.53],0.0087199089865923
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17757,131,1.57 [0.92-2.66],0.0956113202724114
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16841,484,1.23 [0.93-1.64],0.1471061407891919
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,18027,401,1.14 [0.83-1.56],0.4184342932403554
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17916,290,0.92 [0.63-1.34],0.654779775368542
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14649,26,0.81 [0.22-2.98],0.7452710429537641
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16561,1938,1.32 [1.14-1.52],0.0001284733799602
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15001,378,1.05 [0.75-1.46],0.784871251917105
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,20344,138,0.69 [0.39-1.21],0.196590348605756
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20448,38,1.44 [0.54-3.81],0.467343972390653
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18811,37,0.68 [0.24-1.95],0.4717239484207736
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14680,57,3.90 [2.09-7.28],1.887234450258737e-05
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18004,78,1.04 [0.50-2.14],0.9244311284081546
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14885,262,1.77 [1.22-2.56],0.0026126012768916
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17874,248,1.11 [0.74-1.67],0.6053307900003865
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18110,184,0.73 [0.45-1.19],0.2089169190878395
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17997,71,1.00 [0.47-2.14],0.9959058304254516
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16309,26,2.66 [1.00-7.08],0.0496863524951662
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20502,35,2.94 [1.33-6.47],0.0074226212689597
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,18077,451,1.19 [0.89-1.60],0.2465025284487154
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],20223,17,1.40 [0.32-6.10],0.6558253642282862
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19579,1953,1.16 [1.00-1.33],0.0445726088347936
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17717,91,0.78 [0.39-1.53],0.4674634628112244
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18343,417,1.15 [0.84-1.56],0.387786160391715
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19589,171,0.96 [0.59-1.57],0.8722971894786722
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18043,117,0.95 [0.53-1.73],0.8740092594479648
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19030,1104,1.14 [0.94-1.38],0.1859189737962387
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18609,683,1.19 [0.93-1.51],0.1607150466834723
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17659,33,0.68 [0.21-2.12],0.501573674004705
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,20243,37,5.40 [3.13-9.34],1.5168543934869707e-09
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17736,110,1.07 [0.59-1.96],0.8214339335979446
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17645,19,2.38 [0.71-8.01],0.1602222221130035
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14675,52,1.97 [0.88-4.43],0.098639613016076
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19749,1537,1.63 [1.41-1.90],1.5462670306825722e-10
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,20113,338,1.17 [0.83-1.65],0.362812334415025
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19897,122,1.21 [0.68-2.12],0.5165002440361737
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19370,1158,1.50 [1.25-1.79],9.018497722391853e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,20306,49,1.64 [0.72-3.74],0.2351370331836658
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,20304,299,1.62 [1.16-2.28],0.0051554849115077
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,18101,178,1.42 [0.90-2.23],0.1306634981571
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dialysis,18280,68,1.50 [0.72-3.15],0.278294495313701
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19432,2837,1.00 [0.89-1.13],0.9797482408204552
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18547,4754,1.16 [1.06-1.27],0.0013960024220965
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,20332,75,2.83 [1.59-5.04],0.0004216930951237
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydrocele,16770,175,0.70 [0.42-1.14],0.152371770785284
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,18278,293,1.18 [0.81-1.70],0.3896116837491338
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18824,2229,1.02 [0.89-1.17],0.7376050668748904
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16794,199,0.81 [0.51-1.28],0.366126990727477
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17985,62,0.62 [0.27-1.43],0.2602110323020873
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16694,99,1.07 [0.57-2.03],0.8280815036695373
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20506,54,1.84 [0.85-3.98],0.1233756487342798
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20507,46,1.96 [0.88-4.34],0.0984019587653329
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19808,1885,1.19 [1.03-1.37],0.0201570511917068
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18747,824,1.05 [0.85-1.32],0.6387867446858684
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20455,450,1.48 [1.11-1.97],0.0066931835499381
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16860,265,1.19 [0.81-1.75],0.3639008830501939
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16838,243,0.94 [0.62-1.42],0.7664203900748744
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16789,194,0.63 [0.39-1.00],0.0522196368589774
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20501,41,1.04 [0.39-2.78],0.941825931402978
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19182,1259,1.31 [1.10-1.55],0.0024930057018112
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18314,329,1.20 [0.85-1.69],0.3101180399614314
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,20153,148,1.14 [0.68-1.92],0.6181468381296074
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,20313,56,2.48 [1.22-5.05],0.012027866164937
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16821,226,1.29 [0.86-1.95],0.2187508645335695
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20294,2309,1.46 [1.29-1.65],3.862508852376642e-09
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18040,55,1.83 [0.83-4.03],0.135570024833787
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18331,119,1.43 [0.82-2.50],0.2071673975754033
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19838,63,1.03 [0.46-2.28],0.9452191949792712
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18176,253,1.20 [0.81-1.78],0.3639020764392189
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,20216,441,1.22 [0.90-1.64],0.1949996122173823
